RAMON MARTINEZ: Open Payments
NPI 1457376964 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$54,094 in 116 payments from 16 companies in 2025. Trend: 2023 $58,325 · 2024 $87,115 · 2025 $54,094
Speaker / faculty: $36,053Consulting: $7,125Travel & lodging: $4,576Food & beverage: $3,472Speaker / faculty: $2,756Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 35 | $28,674 |
| Teva Pharmaceuticals USA, Inc. | 42 | $21,336 |
| Noven Therapeutics, LLC | 6 | $2,792 |
| Otsuka America Pharmaceutical, Inc. | 8 | $419 |
| Vanda Pharmaceuticals Inc. | 3 | $233 |
| Axsome Therapeutics, Inc. | 4 | $150 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $122 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| Almatica Pharma LLC | 3 | $70 |
| Alkermes, Inc. | 2 | $45 |
Products named: INGREZZA, AUSTEDO XR, Xelstrym, REXULTI, FANAPT, Auvelity, ABILIFY MAINTENA, SPRAVATO.
Industry payments across FL — which companies pay providers there.
